Scarica l'app Stockscreener
1.56
7.67%
-0.12
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TLRY Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.68
Aprire:
$1.68
Volume 24 ore:
46.92M
Relative Volume:
0.62
Capitalizzazione di mercato:
$1.72B
Reddito:
$829.22M
Utile/perdita netta:
$-248.96M
Rapporto P/E:
-5.20
EPS:
-0.3
Flusso di cassa netto:
$-92.10M
1 W Prestazione:
-26.13%
1M Prestazione:
+27.15%
6M Prestazione:
+226.02%
1 anno Prestazione:
-1.82%
Intervallo 1D:
$1.55
$1.6879
Intervallo di 1 settimana:
$1.55
$2.02
Portata 52W:
$0.3507
$2.32
Tilray Brands Inc Stock (TLRY) Company Profile
Nome
Tilray Brands Inc
Settore
Telefono
519.322.8800
Indirizzo
655 MADISON AVENUE, NEW YORK
Confronta TLRY con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TLRY
Tilray Brands Inc
|
1.55 | 1.80B | 829.22M | -248.96M | -92.10M | -0.30 |
|
ZTS
Zoetis Inc
|
143.41 | 63.58B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.93 | 43.58B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.27 | 40.83B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.86 | 23.07B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
432.04 | 19.61B | 3.08B | 1.24B | 1.07B | 25.61 |
Tilray Brands Inc Stock (TLRY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-04-05 | Reiterato | Alliance Global Partners | Neutral |
| 2022-11-02 | Iniziato | Bernstein | Mkt Perform |
| 2022-07-29 | Downgrade | The Benchmark Company | Hold → Sell |
| 2022-03-04 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2021-11-18 | Iniziato | Barclays | Underweight |
| 2021-11-01 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-06-11 | Downgrade | CIBC | Sector Outperform → Neutral |
| 2021-06-03 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2021-05-11 | Ripresa | Cowen | Outperform |
| 2021-05-07 | Ripresa | Jefferies | Buy |
| 2021-05-06 | Iniziato | Canaccord Genuity | Buy |
| 2021-04-28 | Ripresa | BofA Securities | Buy |
| 2021-02-18 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-02-18 | Downgrade | The Benchmark Company | Buy → Hold |
| 2020-11-16 | Downgrade | Jefferies | Hold → Underperform |
| 2020-11-11 | Downgrade | Stifel | Hold → Sell |
| 2020-10-01 | Reiterato | MKM Partners | Neutral |
| 2020-09-21 | Aggiornamento | Jefferies | Underperform → Hold |
| 2020-05-12 | Reiterato | The Benchmark Company | Buy |
| 2020-04-16 | Downgrade | Jefferies | Hold → Underperform |
| 2020-04-09 | Downgrade | Consumer Edge Research | Overweight → Equal Weight |
| 2020-02-24 | Downgrade | Cowen | Outperform → Market Perform |
| 2020-01-13 | Iniziato | BofA/Merrill | Neutral |
| 2019-11-13 | Reiterato | The Benchmark Company | Buy |
| 2019-11-05 | Iniziato | Cantor Fitzgerald | Neutral |
| 2019-10-22 | Reiterato | Piper Jaffray | Overweight |
| 2019-09-20 | Iniziato | MKM Partners | Neutral |
| 2019-08-14 | Reiterato | The Benchmark Company | Buy |
| 2019-07-17 | Iniziato | Ladenburg Thalmann | Neutral |
| 2019-06-28 | Iniziato | Consumer Edge Research | Overweight |
| 2019-06-06 | Iniziato | Stifel | Hold |
| 2019-06-05 | Iniziato | Oppenheimer | Perform |
| 2019-05-15 | Aggiornamento | BMO Capital Markets | Underperform → Market Perform |
| 2019-05-13 | Iniziato | Alliance Global Partners | Neutral |
Mostra tutto
Tilray Brands Inc Borsa (TLRY) Ultime notizie
Tilray (TLRY) Stock Gains Amid Positive Medical Cannabis News - GuruFocus
Why Investors Were Fired Up About Tilray Stock Today - The Globe and Mail
Why Investors Were Fired Up About Tilray Stock Today - The Motley Fool
Tilray Brands (NASDAQ:TLRY) Trading Up 5%Here's What Happened - MarketBeat
Tilray Stock Rises As Study Links Medical Cannabis To Lower Opioid Use - Benzinga
Tilray Brands (TLRY) Upgraded to Buy: What Does It Mean for the Stock? - sharewise.com
Why Did Tilray Stock Soar Recently? - StocksToTrade
Tilray (NASDAQ:TLRY) Trading Activity Sparks Nasdaq Futures Trend - Kalkine Media
Traders Purchase Large Volume of Tilray Brands Call Options (NASDAQ:TLRY) - MarketBeat
Tilray wins huge price target raise from this analyst - Cantech Letter
Cannabis Stocks To Add to Your WatchlistOctober 15th - MarketBeat
Applying big data sentiment scoring on Tilray Brands Inc.Stop Loss & Weekly Sector Rotation Insights - newser.com
Is Tilray Brands Inc. stock bottoming outJuly 2025 Sentiment & Risk Controlled Stock Pick Alerts - newser.com
Visual trend scoring systems applied to Tilray Brands Inc.Weekly Trend Report & AI Based Trade Execution Alerts - newser.com
Pattern recognition hints at Tilray Brands Inc. upsideWeekly Market Report & Comprehensive Market Scan Reports - newser.com
Should You Buy TLRY Stock After Encouraging Q1 Results? - The Globe and Mail
Is Tilray Brands Inc. stock supported by innovation pipelineJuly 2025 Technicals & Real-Time Stock Movement Alerts - newser.com
Tilray Brands (TLRY) Hits All-Time High on Stellar Q1 Earnings - MSN
Tilray Brands (NASDAQ:TLRY) Trading Down 5.3%Time to Sell? - MarketBeat
Tilray’s Wild Ride: What’s Next? - timothysykes.com
How Should Investors View Tilray After a 50% Month Amid Cannabis Legalization Hopes? - Yahoo Finance
Stock Market Today: Tilray Brands Soars After Earnings Beat - AOL.com
Tilray Stock Faces Market Volatility: Time to Reassess? - StocksToTrade
Tilray Medical Enters Joint Venture to Expand Cannabis Operations Into Panama - Cannabis Business Times
Unraveling TLRY’s Volatile Swing: What’s Ahead? - timothysykes.com
Undervalued Small Caps With Insider Buying Across Regions - simplywall.st
Tilray Brands Inc. stock trendline breakdownMarket Movers & Weekly Consistent Profit Watchlists - newser.com
Should you hold or exit Tilray Brands Inc. nowMarket Trend Summary & Free Expert Approved Momentum Trade Ideas - newser.com
(TLRY) Stock Evaluation Report (TLRY:CA) - news.stocktradersdaily.com
Leading vs lagging indicators on Tilray Brands Inc. performanceTrade Volume Report & Real-Time Volume Surge Alerts - newser.com
Tilray Brands Launches Medical Cannabis Business In Panama (NASDAQ:TLRY) - Seeking Alpha
Tilray Brands (NASDAQ:TLRY) Trading Down 1.7%Should You Sell? - MarketBeat
Should You Buy, Sell, Or Hold Tilray Stock After Q1 Earnings? - Barchart.com
Tilray Medical to expand cannabis operations into Panama - Investing.com
Tilray Medical Announces Expansion Plans in Panama, Strengthening Global Cannabis Leadership and Accelerating International Growth - The Manila Times
Tilray (TLRY) Expands Medical Cannabis Operations to Panama - GuruFocus
Tilray Medical Announces Expansion into Panama Through Joint Venture with Top Tech Global Inc. - Quiver Quantitative
Tilray Medical to expand cannabis operations into Panama By Investing.com - Investing.com Canada
Should you sell your Tilray stock? - Cantech Letter
Promising Cannabis Stocks To Watch TodayOctober 13th - MarketBeat
Promising Cannabis Stocks To Follow NowOctober 10th - MarketBeat
Tick level data insight on Tilray Brands Inc. volatilityJuly 2025 Reactions & Accurate Buy Signal Alerts - newser.com
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
Can Tilray Brands Inc. stock deliver strong Q4 earningsWall Street Watch & Verified Technical Signals - newser.com
What dividend safety score for Tilray Brands Inc. stockMarket Sentiment Summary & Risk Adjusted Buy/Sell Alerts - newser.com
Tilray Brands (TLRY) Is Up 6.2% After Posting Surprise Profit and Beating Analyst Expectations - simplywall.st
Cannabis Stocks To Follow NowOctober 12th - MarketBeat
Tilray Stock Dips Amid Market Volatility After Recent Highs - timothysykes.com
Tilray Brands, Inc. (NASDAQ:TLRY) Receives Average Rating of "Hold" from Analysts - MarketBeat
Can Tilray’s 57% Rally Signal a New Trend or Another Bubble in 2025? - simplywall.st
Tilray (TLRY) Losses Worsen, Undercutting Bullish Margin Recovery Narratives - Yahoo
Tilray Brands Inc Azioni (TLRY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Tilray Brands Inc Azioni (TLRY) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Merton Carl A | Chief Financial Officer |
Jul 31 '25 |
Option Exercise |
0.58 |
93,928 |
54,478 |
970,279 |
| Gendel Mitchell | Global General Counsel |
Jul 31 '25 |
Option Exercise |
0.58 |
93,928 |
54,478 |
742,069 |
| Gendel Mitchell | Global General Counsel |
Jul 31 '25 |
Buy |
0.58 |
6,000 |
3,496 |
698,287 |
| FALTISCHEK DENISE M | Chief Strategy Officer |
Jul 31 '25 |
Option Exercise |
0.58 |
93,928 |
54,478 |
874,564 |
| FALTISCHEK DENISE M | Chief Strategy Officer |
Jul 30 '25 |
Option Exercise |
0.61 |
261,194 |
159,328 |
919,069 |
| Herhalt Johann Michael | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
239,930 |
| Looney Thomas P. | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
354,416 |
| Hopkinson David G. | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
335,563 |
| Clanachan David F | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
236,880 |
| Persofsky Renah | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
199,726 |
0.22%
1.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):